RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+40.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.16B
AUM Growth
+$3.16B
(+26%)
Cap. Flow
+$71.7M
Cap. Flow
% of AUM
2.27%
Top 10 Holdings %
Top 10 Hldgs %
29.57%
Holding
150
New
12
Increased
35
Reduced
32
Closed
19
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$73.2M |
| 2 |
Humana
HUM
|
$67.8M |
| 3 |
Aprea Therapeutics
APRE
|
$33.2M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$24.9M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$20.7M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$49M |
| 2 |
MDCO
Medicines Co
MDCO
|
$41.8M |
| 3 |
AbbVie
ABBV
|
$39.8M |
| 4 |
Stryker
SYK
|
$38.7M |
| 5 |
Cigna
CI
|
$29M |
Sector Composition
| 1 | Healthcare | 90.33% |
| 2 | Consumer Staples | 0.66% |
| 3 | Consumer Discretionary | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Galapagos
GLPG
$2.06B
| $36.2M | 1.14% |
175,000
| – | – |
|
|
ONC
27
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $35.6M | 1.13% |
214,800
| – | – |
|
|
RARX
28
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $35.2M | 1.11% |
750,000
-85,000
| -10% | -$3.99M |
|
29
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $35.1M | 1.11% |
1,950,000
+70,000
| +4% | +$1.26M |
|
|
30
Aprea Therapeutics
APRE
$8.91M
| $33.2M | 1.05% |
+723,991
| New | +$33.2M |
|
|
NVRO
31
DELISTED
NEVRO CORP.
NVRO
| $32.8M | 1.04% |
279,000
+36,500
| +15% | +$4.29M |
|
32
Collegium Pharmaceutical
COLL
$1.25B
| $32.4M | 1.02% |
1,575,000
-2,893
| -0.2% | -$59.5K |
|
33
Acadia Healthcare
ACHC
$2.15B
| $32.4M | 1.02% |
975,000
-315,000
| -24% | -$10.5M |
|
34
Idexx Laboratories
IDXX
$50.7B
| $31.4M | 0.99% |
120,200
| – | – |
|
35
Align Technology
ALGN
$9.59B
| $30.9M | 0.98% |
110,900
| – | – |
|
36
Assembly Biosciences
ASMB
$183M
| $30.7M | 0.97% |
1,500,000
+200,000
| +15% | +$4.09M |
|
37
Agios Pharmaceuticals
AGIO
$2.36B
| $30.6M | 0.97% |
641,500
+289,000
| +82% | +$13.8M |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $30.6M | 0.97% |
382,000
+48,500
| +15% | +$3.89M |
|
39
Mirum Pharmaceuticals
MIRM
$3.75B
| $30.5M | 0.96% |
1,245,000
+454,952
| +58% | +$11.2M |
|
|
AXNX
40
DELISTED
Axonics, Inc. Common Stock
AXNX
| $30.5M | 0.96% |
1,100,000
+897,500
| +443% | +$24.9M |
|
41
Amgen
AMGN
$153B
| $30.4M | 0.96% |
126,000
| – | – |
|
42
Ultragenyx Pharmaceutical
RARE
$3.04B
| $29.9M | 0.94% |
700,000
+92,000
| +15% | +$3.93M |
|
43
Ascendis Pharma
ASND
$12.1B
| $29.7M | 0.94% |
213,500
| – | – |
|
44
uniQure
QURE
$954M
| $28.7M | 0.91% |
400,000
+205,500
| +106% | +$14.7M |
|
|
45
Acadia Pharmaceuticals
ACAD
$4.34B
| $28.7M | 0.91% |
670,000
+483,000
| +258% | +$20.7M |
|
46
BioMarin Pharmaceuticals
BMRN
$11.3B
| $28.5M | 0.9% |
337,500
+195,000
| +137% | +$16.5M |
|
|
SGEN
47
DELISTED
Seagen Inc. Common Stock
SGEN
| $27.7M | 0.87% |
242,000
| – | – |
|
48
Thermo Fisher Scientific
TMO
$183B
| $26.3M | 0.83% |
81,000
| – | – |
|
|
DCPH
49
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $26.3M | 0.83% |
421,890
+171,890
| +69% | +$10.7M |
|
|
MDCO
50
DELISTED
Medicines Co
MDCO
| $26.1M | 0.83% |
307,699
-492,301
| -62% | -$41.8M |
|